Latest Amyloid Stories
In a potential breakthrough in the treatment of Alzheimer’s disease, researchers at the University of Illinois at Chicago have determined the molecular structure of one of the proteins found in the fibers of brain plaques linked to this and other neurodegenerative conditions.
Up to 92 percent reduction in transthyretin protein in patients with familial amyloid polyneuropathy CARLSBAD, Calif., April 22, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Issues Concerning Athletes proudly announces its hosting of the #Speedheals Celebrity Bartender Night, a benefit supporting the fight against Amyloidosis and support for children enduring cancer
CAMBRIDGE, Mass., March 16, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Richard Fisher, PhD, the Company's Chief Scientific Officer, will present at the 12(th)
--Funds Will Advance Breakthrough Drug Candidate NPT088 into the Clinic-- CAMBRIDGE, Mass., Jan.
CAMBRIDGE, Mass., Nov.
Dr. Hefti to Lead All Clinical Development Efforts and Strategic Initiatives CAMBRIDGE, Mass., Nov.
New Study Shows Link between Plaques and Tangles/Could Open Door to Therapeutic Target Boston (PRWEB) October 13, 2014 In what is being hailed by scientists
- LUNAR-101, an UNA(TM) oligomer therapeutic for transthyretin-mediated familial amyloid cardiomyopathy (TTR-FAC), exhibited in non-human primates TTR reduction greater than 90% with a single low dose
- A woman chauffeur.
- A woman who operates an automobile.